翻译尚未完成，当前显示原文。
The largest of America's three big drug wholesalers has outperformed the market this year, but is trading at a discount to its five-year median multiple.
我们公开展示核心要点。创建免费账户后可继续阅读全文、保存、讨论，并结合市场和 OSINT 背景分析。
Veytics Intelligence
This drug wholesaler's transformation is paying off. Here's why the stock still looks attractive
